Preemptive Isolation to Prevent Methicillin-Resistant <i>Staphylococcus aureus</i> Cross-Transmission in Diabetic Foot

Lecornet, Emmanuelle; Robert, Jérôme; Jacqueminet, S.; Georges, Ha Van; Jeanne, Sandrine; Bouilloud, F.; Veyrie, C.; Jarlier, Vincent; Grimaldi, A; Hartemann–Heurtier, Agnès

doi:10.2337/dc07-0743

Cited by 13 publications

(12 citation statements)

References 14 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This finding contrasts with other reports 79,80 but used the latest, more sensitive, molecular techniques for identifying MRSA. We have also demonstrated that MRSA can disappear from leg ulcers irrespective of whether or not patients received larval therapy.…”

Section: Contribution Of This Trial To the Evidencecontrasting

confidence: 55%

“…This figure is lower than previously reported figures for a UK diabetic foot clinic (13%) 79 (a study in which MRSA was assessed using MRSA-specific cultures). Other prevalence estimates of MRSA in ulcer patients are 31% for diabetic foot ulcers in patients admitted to a specialised diabetic foot unit in France 80 and 30% in a retrospective analysis of the medical records of patients with chronic ulcers admitted to secondary care; 140 in both cases it is unclear how MRSA was assessed.…”

Section: Mrsamentioning

confidence: 99%

“…77,78 For example, a recent study in a UK diabetic foot ulcer clinic recorded MRSA in 13% of ulcers (where 65% of ulcers were classed as clinically infected) 79 and in France, the leg ulcers of 31% of patients admitted to hospital contained MRSA on admission. 80 A high community prevalence of MRSA in chronic wounds raises the potential for cross-infection, for example during hospitalisation.…”

Section: Existing Evidence For Larval Therapy: Antimicrobial Actionmentioning

confidence: 99%

See 2 more Smart Citations

VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers

Dumville

Worthy²,

Soares³

et al. 2009

Health Technol Assess

View full text Add to dashboard Cite

EA Nelson and DJ Torgerson on behalf of the VenUS II teamHow to obtain copies of this and other HTA programme reports An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below).Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeT he Health Technology Assessment (HTA) programme, part of the National Institute for HealthResearch (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions f...

show abstract

Section: Contribution Of This Trial To the Evidencecontrasting

confidence: 55%

Section: Mrsamentioning

confidence: 99%

Section: Existing Evidence For Larval Therapy: Antimicrobial Actionmentioning

confidence: 99%

See 1 more Smart Citation

VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers

Dumville

Worthy²,

Soares³

et al. 2009

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…Hierzu liegen 3 epidemiologische Studien und 2 Modellierungsstudien vor, die die Effekte präemptiver Isolierungsmaßnah-men evaluieren [264,289,315,331].…”

Section: Kastenunclassified

Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen

Ruscher

2014

Bundesgesundheitsbl.

123

View full text Add to dashboard Cite

“…• at fremmedlegemer har blitt ført gjennom hud eller slimhinner, eller lagt inn gjennom kroppsåpninger, eksempelvis kirurgiske inngrep (også i tannhelsetjenesten), dialyse, innleggelse av venekateter, urinkateter, dren, tube og lignende • sårbehandling, eksempelvis suturering eller stell av større sår 6 Med arbeidet som helsearbeider menes alt pasientrettet arbeid i og utenfor helseinstitusjoner, for eksempel som primaerlege, i hjemmetjenesten, i sykehjem eller sykehus, i bistands-eller nødhjelpsarbeid. 7 Flere miljøer enn de nevnte kan ha økt forekomst av MRSA.…”

Section: Tiltak I Sykehusunclassified

Are measures against MRSA transmission effective?

Haug¹

2018

Tidsskriftet

View full text Add to dashboard Cite

Preemptive Isolation to Prevent Methicillin-Resistant Staphylococcus aureus Cross-Transmission in Diabetic Foot

Cited by 13 publications

References 14 publications

VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers

VenUS II: a randomised controlled trial of larval therapy in the management of leg ulcers

Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen

Are measures against MRSA transmission effective?

Contact Info

Product

Resources

About